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To the Editor: Moore et al. report-
ed a case series of patients infected
with imported gnathostomiasis who
had typical intermittent, migratory
skin manifestations or peripheral
blood eosinophilia or both, as well as
undiagnosed eosinophilia with non-
specific symptoms (1). We would like
to add some comments based on a
recent patient treated in Marseille,
France.
In April 2003, a 66-year-old man
living in Marseille indicated a history
of fever for 8 days. He had returned
from Vietnam 1 month earlier, where
he had stayed for 4 weeks in the Ho
Chi Minh City area and 2 days in the
Mekong Delta area. He was well dur-
ing his trip, and reported no arthropod
bites except from mosquitoes. He had
no direct skin contact with river water.
Dietary intake included local dishes
with rice, fish, pork, shrimp, and
chicken. His symptoms started 3
weeks after he returned to Marseille
and included fever (temperature
38°C), asthenia, chills (1 day), moder-
ate dyspnea during exercise, transient
bilateral pain of the testes, and an
episode of hemospermia. He was
referred by his family doctor to the
Infectious and Tropical Diseases Unit,
North Hospital. 
On admission, the patient’s temper-
ature was 38°C. Physical examination
of the patient, including the testes, was
normal except for a systolic heart mur-
mur (preexisting and known to the
patient), and clinical signs of left pleu-
ral effusion. The effusion was subse-
quently confirmed by chest x-ray,
which also showed a discrete diffuse
bilateral lung infiltrate. Results of rou-
tine laboratory tests conducted on
blood samples were normal except for
an elevated eosinophil count of 5.2
109/L. Blood smears for plasmodia
and microfilaremia were negative.
Urologic examination, including
echography and prostate-specific anti-
gen, showed no abnormalities except a
prostatic adenoma (preexisting and
known to the patient). No eggs or par-
asites were detected by microscopic
examination in stools or in urine,
although both sedimented and cen-
trifuged urine specimens were studied
and filtration techniques were used.
After transthoracic aspiration of 100
mL of pleural effusion, cytologic
examination showed an eosinophil
count of 5,800/L without parasites.
Bacterial culture, including mycobac-
teria, was negative. On day 4, the
patient was afebrile and was dis-
charged. On admission, results of a
first set of examinations involving
reactivities to schistosomiasis, parago-
nimiasis, strongyloidiasis, cysticerco-
sis, trichinosis, gnathostomiasis, filari-
asis, and toxocariasis were negative.
One month later, the eosinophil
count of our patient had decreased to
1.8 x 109/L. He was afebrile, and his
only complaint was asthenia. A new
set of serologic examinations was
conducted. The Western blot assay for
gnathostomiasis conducted at the
Swiss Tropical Institute (Socinstrasse
57, CH-4002, Basel, Switzerland) was
positive, showing immunoglobulin G
reactivity to four specific bands
including the 24-kDa band, consid-
ered pathognomonic for the diagnosis
of  Gnathostoma infection (1). The
seroconversion confirmed the diagno-
sis of gnathostomiasis. All other sero-
logic tests remained negative, except
an increase of antibodies against
Acanthocheilonema vitae used as
antigen for unspecific serologic
screening for filariasis (Laboratoire
Marcel Merieux, Lyon, France). After
a 21-day course of albendazole and a
single dose of ivermectin, the
eosinophil count of our patient
decreased to 0.8 x 109/L.
Three aspects of gnathostomiasis
as an emerging imported disease can
complement the findings of Moore et
al. (1). First, the clinical findings in
our case are very unusual. Hemo-
spermia is often benign with predomi-
nant causes including prostatic and
seminal vesicle disease. Infections,
including mainly schistosomiasis and
tuberculosis, have been associated
with these symptoms (2). Although
our patient had a prostatic adenoma,
this is the first time that hemospermia
has been associated with gnathostomi-
asis. Because of the anxiety hemosper-
mia caused, this symptom was the
main reason that our patient consulted
our center. Secondly, eosinophilic
pleural effusion is also unusual in
gnathosthosmiasis. Although reported
as a potential cause in reference books
(3), a Medline search (key words:
gnathostomiasis and eosinophilia and
pleural effusion or pleuritis or lung)
disclosed only two references to pleu-
ral  effusion as the main symptom of
gnathostomiasis (4,5). 
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The eosinophilic pleural and pul-
monary response may be elicited by
the larvae of helminths carried
hematogenously into lungs and pleura
in an aberrant fashion (3). The last
point we stress is that, as shown by
Moore et al. (1), patients returning
from disease-endemic areas, mainly
Southeast Asia and Central and South
America, should be tested systemati-
cally for gnathostomiasis. Although
some patients show a typical cuta-
neous form of gnathostomiasis associ-
ated with eosinophilia (6,7), most
atypical forms are probably under-
diagnosed, and severe neurologic
involvement may occur if treatment is
not given (1). However, until recently
specific serologic tests for gnathosto-
miasis were available only in Asia,
mainly in Thailand and Japan. Some
laboratories in Europe currently pro-
vide testing for gnathostomiasis,
which would be a valuable aid in eval-
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To the Editor: This letter is writ-
ten in response to the article titled
“Co-trimoxazole-sensitive, methi-
cillin-resistant Staphylococcus aureus,
Israel, 1988–1997” (1). We found the
authors’ findings most interesting. As
the authors pointed out, methicillin-
resistant  Staphylococcus aureus
(MRSA) infections have become a
major problem worldwide. The prob-
lem is not restricted to industrialized
countries. The last decade has seen an
alarming increase in MRSAinfections
in Pakistani hospitals (2). Pakistan’s
Armed Forces Institute of Pathology
provides laboratory services to a
1,500-bed tertiary-care hospital in
Rawalpindi and is the main reference
laboratory in northern Pakistan.
According to our computerized data-
base, the frequency of MRSA among
all nosocomial isolates of S. aureus
increased from 39% (212/543) in
1996 to 51% (516/1,018) in 2003 (p <
0.0001). Most of the isolates were
obtained from pus and pus swab spec-
imens (153 in 1996 and 394 in 2003),
while the rest were obtained from
blood (20 in 1996 and 37 in 2003),
intravenous catheter tips and surgical
drainage tubes (14 in 1996 and 31 in
2003), various body fluids (9 in 1996
and 19 in 2003), respiratory secretions
(8 in 1996 and 18 in 2003), tissue (4
in 1996, 9 in 2003), throat swabs (2 in
1996, 6 in 2003), and urine (2 in 1996,
5 in 2003).
During the last 7 years, resistance
in MRSA isolates has steadily
increased to most of the antimicrobial
drugs such as gentamicin (69% in
1996 and 88% in 2003), ciprofloxacin
(87% in 1996 and 94% in 2003), clin-
damycin (60% in 1996 and 70% in
2003), and rifampicin (20% in 1996
and 60% in 2003). However, resist-
ance to co-trimoxazole and doxycy-
cline has decreased. In 1996, 15%
(32/212) of our MRSA isolates were
susceptible to co-trimoxazole, where-
as in the first 9 months of 2003, 43%
(222/516) of the isolates were suscep-
tible (p < 0.0001). Similarly, suscepti-
bility to doxycycline increased from
34% in 1996 to 49% in 2003 (p =
0.0005). Antimicrobial drug suscepti-
bility of the isolates was tested by the
modified Kirby-Bauer technique and
results were interpreted according to
the National Committee for Clinical
Laboratory Standards criteria (3).
Methicillin resistance was tested by
using 1 µg oxacillin disks (Oxoid,
Basingstoke, Hampshire, UK) on
Mueller-Hinton agar containing 4%
sodium chloride. Plates were incubat-
ed at 35°C for 24 hours.
We agree with Bishara et al. (1)
that the increase in susceptibility is
likely due to decreased use of these
antimicrobial drugs for staphylococ-
cal infections in clinical practice. The
use of co-trimoxazole in our hospital
decreased from 48 daily doses per
1,000 hospital days in 1996 to 35
daily doses in 2003, while use of
doxycycline decreased from 12 daily
doses per 1,000 hospital days in 1996
to 9 daily doses in 2003 (4). These
antimicrobial drugs offer an inexpen-
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